Loading...
•
Dec 31, 2025
Albemarle Q4 2025 Earnings Report
Albemarle reported its financial results for the fourth quarter and full year ended December 31, 2025, showing increased net sales and adjusted EBITDA in Q4, despite a net loss.
Key Takeaways
Albemarle Corporation delivered strong fourth quarter results with net sales up 16% to $1.4 billion and adjusted EBITDA increasing 7% to $269 million, driven by volume gains in Energy Storage and Ketjen. The company reported a net loss of $414 million, primarily due to tax-related items and asset write-downs, but adjusted diluted loss per share improved significantly.
Fourth quarter net sales reached $1.4 billion, a 16% increase year-over-year, with volume growth across all segments, notably Energy Storage (+17%) and Ketjen (+13%).
The company reported a net loss of $414 million, or ($3.87) per diluted share, which included significant tax-related items and asset write-downs related to the Ketjen transaction.
Adjusted EBITDA for the fourth quarter was $269 million, up 7% from the prior year, primarily driven by strong performance in Energy Storage (+25%) and Ketjen (+39%).
Albemarle achieved approximately $450 million in cost and productivity improvements for the full year, exceeding its initial target, and generated $692 million in free cash flow.
Revenue by Segment
Forward Guidance
Albemarle's 2026 outlook considers various lithium market price scenarios, with expected flat capital expenditures and meaningful free cash flow generation, assuming improved lithium market conditions.
Positive Outlook
- New scenarios highlight improved lithium market conditions and operational performance.
- Full-year 2026 capital expenditures are expected to be approximately flat year-over-year, reflecting consistent sustaining capital and targeted growth.
- Meaningful free cash flow generation is anticipated, assuming recent higher lithium prices.
- Energy Storage production volumes are expected to increase year-over-year.
- Specialties outlook reflects modest volume growth in key end markets like semiconductor and pharmaceutical.
Challenges Ahead
- Sales volumes are expected to be approximately flat following inventory drawdowns that occurred in 2025.
- Specialties net sales are expected to be flat to down in 2026 compared to 2025.
- Specialties adjusted EBITDA is expected to be lower in 2026 compared to 2025 due to lower lithium specialties pricing.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...